JNJ

4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Ex-J&J chief's 2012 pay outclasses Gorsky's by almost 3-to-1
Fierce Pharma
Fri, 03/15/13 - 11:44 am
JNJ
executive pay
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
Seeking Alpha
Fri, 03/15/13 - 10:57 am
Incivek
Vertex Pharmaceuticals
Gilead
GSK
JNJ
Kalydeco
cystic fibrosis
hepatitis C
J&J Subsidiary Cordis Buys Flexible Stenting Solutions
Motley Fool
Fri, 03/15/13 - 10:55 am
JNJ
Cordis
stents
Flexible Stenting Solutions
M&A
J&J’s Ekdahl Says Hip Recalled for Clinical Reasons
Bloomberg
Thu, 03/14/13 - 08:20 am
JNJ
DePuy
hip impants
recalls
Johnson & Johnson cuts bonuses for new CEO, other execs by 10 percent due to 'disappointments'
Yahoo/AP
Thu, 03/14/13 - 08:19 am
JNJ
executive pay
Overseas Tax Savings for U.S. Drugmakers Under Threat
Bloomberg
Tue, 03/12/13 - 11:28 am
Pfizer
Merck
JNJ
Bristol-Myers Squibb
taxes
J&J Seeks EU Nod for Combo Drug
Yahoo/Zacks
Tue, 03/12/13 - 11:24 am
Europe
JNJ
diabetes
canagliflozin
metformin
J&J Faces Second Trial Over Recalled Hip After Loss
Bloomberg
Mon, 03/11/13 - 10:40 am
recalls
JNJ
hip implants
The Best Choice in Healthcare, Period
Motley Fool
Sun, 03/10/13 - 12:05 pm
JNJ
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/9/13 - 12:45 pm
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Hip Defect Could Cost Johnson & Johnson Billions
Wall Street Cheat Street
Sat, 03/9/13 - 12:33 pm
hip implants
hip recall
recall
JNJ
lawsuits
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha
Sat, 03/9/13 - 12:29 pm
type 2 diabetes
JNJ
diabetes
canagliflozin
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Forbes
Fri, 03/8/13 - 11:03 am
JNJ
diabetes
canagliflozin
Pharmaceutical Winners And Losers In Early 2013
Motley Fool
Fri, 03/8/13 - 10:06 am
Eli Lilly
JNJ
Sanofi
Teva
Bayer eyes wider use for Xarelto with new trials
Reuters
Fri, 03/8/13 - 10:05 am
Bayer
Xarelto
JNJ
percutaneous coronary intervention.
Aspen Pharmacare Offers Very Expensive Developing World Growth
Seeking Alpha
Thu, 03/7/13 - 11:32 am
Aspen Pharmacare
GSK
JNJ
Novartis
Sanofi
South Africa
The FDA Gift That Keeps On Giving
Motley Fool
Thu, 03/7/13 - 11:31 am
FDA
Bayer
JNJ
Xarelto
Are Antibiotics Dead Weight for Johnson & Johnson?
Motley Fool
Thu, 03/7/13 - 11:29 am
JNJ
antibiotics
Can Anything Stop Johnson & Johnson?
Motley Fool
Wed, 03/6/13 - 09:56 am
JNJ

Pages